Platinum-DNA adduct in leukocyte DNA of a cohort of 49 patients with 24 different types of malignancies.

Reed, E; Parker, R J; Gill, I; Bicher, A; Dabholkar, M; Vionnet, J A; Bostick-Bruton, F; Tarone, R; Muggia, F M

Reed, E; Parker, R J; Gill, I; Bicher, A; Dabholkar, M; Vionnet, J A; Bostick-Bruton, F; Tarone, R; Muggia, F M.

Affiliation

Reed E; Medicine Branch, National Cancer Institute, Bethesda, Maryland 20892.

Cancer Res ; 53(16): 3694-9, 1993 Aug 15.

Article in En | MEDLINE | ID: mdl-8339278

Subject(s)

Carboplatin/metabolism; Cisplatin/blood; DNA Adducts; DNA/blood; Leukocytes/metabolism; Neoplasms/blood; Carboplatin/therapeutic use; Cisplatin/analysis; DNA/analysis; Humans; Leukocytes/chemistry; Neoplasms/drug therapy; Prospective Studies; Spectrophotometry, Atomic

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: DNA / Carboplatin / Cisplatin / DNA Adducts / Leukocytes / Neoplasms Type of study: Observational_studies Limits: Humans Language: En Journal: Cancer Res Year: 1993 Type: Article

Search on Google

XML

PubMed Links